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ABSTRACT 
 
Combination Anthelmintics to Control Gastrointestinal Nematodes in Foals. 
 (December 2011) 
Joe Luke Luksovsky, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Thomas M. Craig 
 
A study was undertaken to evaluate and compare the effectiveness of three 
anthelmintics, ivermectin, fenbendazole, and a combination of ivermectin and pyrantel 
pamoate, on fecal egg count reductions of cyathostomes and Parascaris equorum in 30 
foals at the Texas A&M Horse Center. The foals were reared under standard horse center 
practices and were naturally infected with both cyathostomes and Parascaris. The foals 
were randomized into three treatment groups with individuals being rerandomized after 
each eight week observation period. The treatments of ivermectin and fenbendazole 
were given at the manufacturer’s recommended doses and the pyrantel treatment was 
given at two times the manufacturer’s recommended dose. All doses were based on 
weights taken prior to treatment. Fecal egg counts were performed at the time of 
treatment and at two week intervals after treatment for a total of eight weeks. Each foal 
received a total of three treatments during the course of the study along with the most 
effective treatment at the conclusion of the study. Fecal egg counts were performed by a 
modified McMaster’s test with a sensitivity of 25 eggs per gram of feces and by the 
modified Wisconsin double centrifugal floatation with a sensitivity of 0.2 eggs per gram 
 iv 
of feces. Fecal egg reduction percentages were calculated for each two week interval. 
Analysis of the results showed that ivermectin, either used alone or with pyrantel was a 
more effective anthelmintic for cyathostome (small strongyle) control than 
fenbendazole. Fenbendazole and pyrantel showed a higher initial reduction in 
Parascasris eggs when compared to the ivermectin only treated group, but ivermectin 
showed improved egg reduction over time. At the conclusion of this study, a primary 
treatment of ivermectin at the manufacturer’s recommended dose and treatment of 
pyrantel at two times the manufacturer’s recommended dose was recommended to 
control cyathostome egg production and severely reduce the initial number of Parascaris 
adults in the foals at this facility. Subsequent monthly does of ivermectin at the 
manufacturer’s recommended dose was also recommended to continue to control both 
parasites. Follow up fecal examinations were also recommended to test the continued 
effectiveness of the recommended treatment protocol. 
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1. INTRODUCTION 
 
 
 
The purpose of this study is to determine the effect of specific anthelmintics, or a 
combination of anthelmintics on controlling gastrointestinal nematodes in foals, 
specifically Parascaris equorum and cyathostomes, (small strongyles) at a single farm. 
Through this study, insights into which drug or drugs have the most affect on the 
particular farm being treated will be observed. Both these parasites are commonly found 
in horses, though Parascaris is usually found in young or naïve animals, while 
cyathostomes are found in horses or all ages. Both are acquired when a horse ingests the 
infective stages of the parasite while grazing, the L3 larvae in the case of cyathostomes 
and the larvated eggs of Parascaris. Once inside the host, the parasites begin the process 
of maturing and taking up residence in the niche within the intestinal tract of the horse 
most suited for their needs. Parascaris adults are found in the small intestine and 
cyathostome adults live in the lumen of the large intestine. At this time, the two most 
important gastrointestinal nematodes of foals are Parascaris equorum, and cyathostomes 
(small strongyles). If uncontrolled, these parasites can adversely affect the foal’s health.   
 
 
 
 
____________ 
This thesis follows the style of Veterinary Parasitology. 
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1.1 Disease and Life Cycle 
 
 
 
Parascaris equorum can cause lung damage by focal hemorrhages from larval 
migration, catarrhal enteritis (intestinal inflammation), ill thrift, and even death 
(Urquhart et al., 1996). It can also lead to poor growth, colic, and intestinal impaction or 
perforation, and is considered the most pathogenic parasite of juvenile equids 
(Reinemeyer, 2009).  Parascaris equorum is a large roundworm, 15-50 cm long, which 
inhabits the small intestine of immature horses throughout the world. Horses are infected 
when they ingest larvated eggs from the environment. Once ingested, the L2 larvae 
emerge from the eggs within the alimentary tract of the horse, penetrate the intestinal 
wall, and passively migrate to the liver. The larvae reach the liver in as little as two days 
post infection with most migrating through by seven days post ingestion (Clayton et al., 
1978). From the liver, the larvae migrate to the lungs via the portal system of blood 
vessels. The majority of larvae reach the lungs between fourteen and twenty-three days 
post infection (Clayton et al., 1978).  From here they are coughed up and swallowed, 
they molt to the final larval stage, then to adults in the small intestine. It takes between 
twenty-three and thirty-seven days for the larvae to migrate back to the small intestine 
post infection with some larvae being seen in as little as fourteen days (Clayton et al., 
1978). Not all larvae that make it to the small intestine become adults, competition for 
resources and space limit numbers, one study found that of 4150 larvae that emerged 
into the small intestine, only 123 adults remain four months later (Clayton et al., 1978).  
Both the larval stage and adults found in the intestine feed on ingesta of the host. The 
3 
 
time from ingestion of the infective egg to establishment in the small intestine takes 
about one month with 75-80 days required from infection to reproduction by an adult 
worm. Adult females can produce thousands of eggs each day. In the environment, the 
eggs become infective in as short as 10 days, and can survive for as long as 10 years 
(Reinemeyer, 2009). Parascaris is unusual in that hosts can develop absolute immunity 
to this nematode, thus older horses that have been exposed previously to the helminth 
rarely show signs of disease. 
Cyathostomes, small non-migratory strongyles, are a group of parasites that 
reside on the surface or in the luminal contents of the large intestine of equids 
(Ogbourne, 1976). At least forty separate species make up this group of parasites.  The 
eggs and larvae of these parasites cannot be differentiated among species, but 
morphological features can be used to separate adults. Features such as buccal capsule 
shape, presence or absence of teeth or plates in the buccal capsule, and elements of the 
corona radiata are morphologic determinate of each cyathostome species. Different 
species also have preferred developing sites, Cylicocyclus nassatus, Cylicostephanus 
minutes, C. calicatus and Cyathostomum catinatum are usually found in the ventral 
colon. In the dorsal colon, Cylicostephanus longiburastus, C. goldi, and C. insigne 
predominate. Coronocyclus coraonatum and Petrovinema poculatum develop in the 
cecum, but other genera of cyathostomes may colonize the cecum after emergence from 
the mucosa (Ogbourne, 1978).  
Infection occurs when an equine ingests the L3 larvae from the environment. 
Once in the body, the L3 exsheath and invade the mucosa of the large intestine through 
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the glands of Lieberkuhn (Ogbourne, 1978). Most cyathostomes only burrow into the 
mucosa, but a few species, such as Cylicostephanus longibursatus will penetrate into the 
submucosa (Ogbourne, 1978). Once embedded in the mucosa, the L3 larvae will either 
molt to the L4 stage or arrest development (hypobiosis) (Eysker et al., 1986). The L4 
stage, larvae subsequently emerge into the lumen of the large intestine. The prepatent 
period (the time it takes from when larvae are ingested, to when adults shed eggs) varies 
on species, from a minimum of 35 days to as long as 10-13 weeks if hypobiosis does not 
occur (Poynter, 1969). Once in the lumen, the L4’s develop into adults and reproduce, 
shedding eggs into the environment. 
Within the egg, larvae (L1) are found in a matter of days at a minimum 
temperature of 10 C (Lucker, 1941). Once the L1 larva is fully developed, it hatches 
from the egg and feeds on bacteria in the fecal mass. After feeding, the L1 molts to an 
L2 larva. The L2 will then molt to the L3 infective stage, which is encased in a 
protective sheath, the cuticle from the L2 stage. This sheath is vital for prolonged 
survivability, as it protects the larva from desiccation in the environment. Once the 
parasite reaches its infective stage, it will ascend the surrounding vegetation in an effort 
to increase its chances for being ingested by a viable host. Egg and larval development 
and survivability are dependent on climate, with high temperatures causing more rapid 
development to L3 larvae (Ogbourne, 1973). In tropical and subtropical climates, 
infective larvae can be found on herbage throughout the year, with peak concentrations 
during the cooler month, mid-September thru March (Baudena et al, 2000). In Texas, the 
peak month of acquisition is November. Temperatures optimal for cyathostome larva 
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development are between 10-18 C, but can develop in temperatures between 5-33 C. 
Oddly enough, moisture has a negative effect on the survivability of infective L3 
cyathostome larvae, but is essential for development up-to that stage (Baudena et al, 
2000). The theory behind this occurrence is that increased moisture levels cause 
increased osmotic stress to the L3 larvae, especially if the moisture levels fluctuate 
rapidly, weakening the larvae’s protective sheath (Mfitilodze, 1988).  
Cyathostomes can affect foals in the following ways: ulceration of the mucosa of 
the large intestine, diarrhea, colitis, peritonitis, ill thrift, and weight loss (Urquhart et al., 
1996). In animals six months to one year of age, heavy infections can cause catarrhal and 
hemorrhagic enteritis along with mucosal thickening and edema. Disease caused by 
cyathostomes is not limited to young animals, but can affect older horses as well. The 
larvae of cyathostomes encyst in the mucosa of the cecum and colon and cause disease 
during emergence, usually between late fall and early spring. The disease, known as 
cyathostomiasis, is characterized by sudden onset watery diarrhea and inflammation of 
the mucous membranes, emaciation, weight loss, hypoalbuminemia, possible anascara 
(extreme generalized edema), and even death. Cyathostome infection has been 
implicated as the cause of sudden-onset diarrhea syndrome which leads to emaciation 
and death in as little as two to three weeks (Love et al., 1999).  During the winter and 
spring cyathostomiasis occurs as more larvae enter the intestinal lumen than the horse 
can support and many larvae and adult cyathostomes may appear in the feces (Bowman, 
2009). A major reason for cyathostomiasis is hypobiosis due to competitive inhibition. If 
the horse already had a substantial cyathostome load at the time the larvae were ingested, 
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the larvae could arrest development and wait until adult populations in the lumen had 
fallen before completing their development. Since parasite acquisition naturally is 
lessened in the late fall and winter due to reduced grazing, and thus reduced larvae 
ingestion, the lack of adults in the lumen of the horse triggers a mass emergence of the 
larvae that were in hypobiosis. Cyathostomes can also be the cause of a recurrent 
diarrhea in ponies where the parasites cause rapid weight loss, severe peripheral edema 
and pyrexia without diarrhea. The first clinical sign of this disease is weight loss, which 
lasts for several months before the start of diarrhea (Love et al., 1999). Cyathostomes 
have been linked to various forms of equine colic including non-strangulation infarction 
and caecal tympany (colic with distension of the abdomen), as well as mild colics (Love 
et al., 1999). 
 
 
                                            1.2 Treatments 
 
 
 
Three classes of anthelmintics have widely been used to control gastrointestinal 
nematodes in horses in the United States. These are the benzimidazoles: fenbendazole, 
oxfendazole, and oxifendazole; tetrahydropyrimidines, the pyrantel salts; and 
macrocyclic lactones or avermectin-milbemycins: ivermectin and moxydectin. The 
benzimidazoles work by inhibiting the nematode’s energy metabolism. It starves the 
worm by inhibiting microtubular polymerization, which decreases nutrient absorption in 
the worm’s intestine. The tetrahydropyrimidines cause continuous firing of neuro-
muscular junctions by stimulating the acetylcholine agonists forcing all muscles to 
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constrict causing rigid paralysis. The macrocyclic lactones act on the worm by 
enhancing the effect of γ-aminobutyric acid, a neurotransmitter, causing permanent 
flaccid paralysis. This, in effect, makes it impossible for the parasite to maintain itself in 
the intestinal lumen of the host and it is eliminated (Austin et al., 1991). When first 
developed, these anthelmintics worked well against cyathostomes and Parascaris, but, 
like many drugs, resistance is increasing to these medications.  
 
 
                                  1.3 Anthelmintic Resistance 
 
 
 
The first case of anthelmintic resistance in horses was reported over fifty years 
ago when phenothiazine failed to reduce Strongyle egg counts. Today, resistance to 
anthelmintics has been reported in virtually every drug in use throughout the world, 
especially in the Netherlands, Canada, the United States, Denmark, Germany, Brazil, 
and Italy (Reinemeyer, 2009). Today, drug resistance in cyathostomes has been reported 
from benzimidazoles (almost total insusceptibility), pyrantel salts, piperazine and 
macrocyclic lactones, the most commonly used anthelmintics on the market 
(Reinemeyer, 2009). This does not mean that no current drug on the market will kill 
helminths, but it does mean that horse owners and veterinarians must know which 
anthelmintics will work on each particular farm.  
Kaplan et al., (2004) published a study of 1,274 horses from 44 farms in Georgia, 
South Carolina, Florida, Kentucky, and Louisiana to determine anthelmintic resistance 
to cyathostomes. The authors used four different anthelmintics: fenbendazole, 
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oxibendizole, pyrantel pamoate, and ivermectin. The data collected from 786 of the 
1,274 horses in this study indicated fecal egg count reductions of 24.8% for 
fenbendazole, 73.8% for oxibedazole, 78.6% for pyrantel pamoate, and 99.9% for 
ivermectin for Strongyle type eggs (cyathostomes). Using the suggested <90% egg count 
reduction as a measure of resistance, Kaplan et al. (2004) determined that parasites on 
these farms had a 97.7% resistance to fenbendazole, a 53.5% resistance to oxibendazole, 
and a 40.5% resistance to pyrantel pamoate. No resistance was detected to ivermectin in 
this study. 
 Likewise, Lyons et al. (2006) had similar results in a study of seven farms in 
central Kentucky. The authors found that ivermectin was effective against cyathostomes 
but pyrantel pamoate, fenbendazole, and oxibendazole were not. Six of the seven farms 
utilized in the study harbored Parascaris equorum and all seven had persistent 
cyathostome infections in at least one foal due to anthelmenthic resistance.  
 Hearn and Peregrine (2003) suspected a failure of ivermectin to control 
Parascaris equorum in a large horse farm near Toronto, Ontario. The researchers took 
samples from 16 foals three and one-half to eight months of age. After completing egg 
counts, the foals were treated with the manufacturer’s suggested dose of ivermectin and 
retested 12 days later. Thirteen of the 16 foals still had eggs in the feces and seven of the 
animals showed an increase in egg numbers. The researchers then tested 21 more foals 
that had been treated at the same time as the 16 animals from the study and found that 12 
horses still had eggs present in the feces. Further investigation revealed that foals that 
had spent their entire lives on the farm and were treated solely with ivermectin were 
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significantly more likely to have Parascaris egg counts of over 100 eggs per gram of 
feces than foals who received a drug other than ivermectin sometime in their lives, or 
foals who were brought in from other farms. Past studies suggested that ivermectin 
should eliminate all Parascaris egg production by seven days post treatment and prevent 
egg production for at least 35 days post treatment. Since eggs were found 12 days post 
treatment the authors had strong evidence that ivermectin’s effectiveness had fallen, at 
least for this particular farm. 
Slocombe et al. (2006) tried to determine a treatment protocol for Parascaris 
equorum. This clinical trial used 76 foals on three farms in southwestern Ontario. The 
researchers administered ivermectin, moxidectin, fenbendazole, and pyrantel pamoate at 
the manufacturer’s recommended doses. Two farms were determined to have Parascaris 
equorum resistance to ivermectin and moxidectin. On the other farm marked egg count 
reductions were found, but they were also found in the untreated group leading the 
researches to believe that the reductions were due to natural age related immunity to the 
nematode; however, a later trial on the same farm showed a resistance to ivermectin. 
This finding is evidence that ivermectin worked in older foals, but not in younger ones. 
Overall effectiveness for Parascaris, determined by fecal egg count reduction on all 
farms, was 33.5% for ivermectin, 47.2% for moxidectin, and 97.6% for fenbendazole 
and pyrantel pamoate combined.  
Craig et al. (2007) conducted a study on 32 foals from a single Texas horse farm 
to determine anthelmintic resistance. The farm had used ivermectin since 1984 as the 
primary anthelmentic. In 2002, pyrantel pamoate was rotated into the treatments. The 
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foals were treated with either ivermectin or pyrantel or a combination of both, depending 
on which species of nematode eggs were detected in the feces. At the study’s conclusion, 
24 of the foals on ivermectin developed patent Parascaris infections suggesting that 
ivermectin had become less effective due to increased tolerance by the nematode. The 
foals who received pyrantel at two times the manufacturer’s recommended dose had a 
98-100% reduction in Parascaris egg counts. Cyathostome eggs were reduced by 99.9% 
with ivermectin at 0.2 mg/kg, but only a 60.4% decrease occurred in pyrantel treated 
foals. This indicates that pyrantel’s effectiveness against cyathostomes was waning as of 
2007 as was ivermectin’s effectiveness against Parascaris. Pyrantel resistance by 
cyathostomes has been reported throughout the southeastern United States, Canada, and 
northern Europe (Kaplan et al., 2004). 
Although ivermectin is still widely used for treating cyathostomes, tolerance or 
resistance is increasing. A horse farm in central Kentucky was used to study the time 
frame from treatment to the reappearance of cyathostome eggs in the feces (Lyons et al, 
2008a). The paper stated that this time interval should have been eight weeks. Testing 
yearlings and older horses, the investigators found that eggs started reappearing between 
25 and 28 days in yearlings and 27 and 33days in older horses. The study concluded that 
eggs reappear at around four weeks post treatment with ivermectin in the young animals, 
half the time reported when the drug was first introduced, and show increases in egg 
numbers in weeks five and six. The authors also found that egg per gram counts rose 
twice as fast as when ivermectin was first utilized in 1983. Lyons et al. (2008a) believe 
that this field test shows a selection of a resistant phenotype in which the adult worms 
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survive with temporarily inhibited egg production. This observation could also be 
explained by emergent larvae that received an insufficient dose of ivermectin at the time 
of treatment. Since ivermectin is absorbed by the horse then metabolized slowly, 
cyathostome larvae emerging into the lumen shortly after treatment would have 
sufficient time to mature and produce eggs by four weeks post treatment, especially if 
they are resistant to levels of ivermectin that are lower than the manufacturer’s 
recommended dosage levels. 
 Findings such as these should raise a concern with any horse owner. The 
observations from the above studies indicate that the effectiveness of benzimidazole and 
pyrantel anthelmintics are not at the level they were when the drugs first came on the 
market for treating cyathostomes; in fact, they have fallen to under the 90% standard 
reduction percentage that determines effectiveness. The only drugs that still have such 
effectiveness on cyathostomes is the macrocyclic lactones such as ivermectin and 
moxydectin, and as Lyons (2006, 2008a, 2008b) observed, even that is on the wane. As 
for Parascaris treatment, studies such as the ones by Craig (2007) and Slocombe (2006) 
clearly show that ivermectin is ineffective at lowering egg levels on the farms that were 
tested. Knowing that single anthelmintic treatment regimens may not control all the 
parasites on a farm, and that such a treatment program is selective for resistance, a 
multidrug approach may be required to control parasite populations on farms with 
anthelmintic resistance and thus prolong the effectiveness of the anthelmintics being 
used. There has been previous work on multidrug helminthic control. Rehbein et al. 
(2007) conducted a study in which they used 30, 18 month old ponies in New Forest, 
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United Kingdom. The ponies were treated with an ivermectin/praziquantel paste that was 
1.55% ivermectin and 7.55% praziquantel which equals 0.2 mg and 1mg per kg, 
respectively. Ivermectin was used to target the cyathostomes, Parascaris, and bots, 
while praziquantel was used for tapeworm control. The study found the efficacy of the 
paste to be 100% against cyathostomes and Parascaris, along with tapeworms and bots. 
This treatment protocol is included here to demonstrate that anthelmintics of different 
modes of action can be used concurrently without counteracting each other. 
 From these past studies, it is easy to deduce that parasitic nematodes are 
becoming resistant to current anthelmintics now on the market. It is also evident that 
some drugs produce better results than others on each farm depending on which 
anthelmintics have been used on that farm in the past. Furthermore, drugs that are 
extremely effective on one farm may not have the same effect on another, or if a drug 
failed to produce optimal control levels on one farm, it doesn’t mean that it will not work 
to control parasites at yet another location. To treat cyathostomes and Parascaris, one 
must know which anthelmithics will work on the particular farm being treated. 
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2. MATERIALS AND METHODS 
 
 
 
 For this trial, 30 Quarter Horse foals born at the Texas A&M University Horse 
Center were used. The foals were maintained in accordance with normal Horse Center 
practices as far as vaccinations, health issues, etc. The foals were naturally exposed to 
Parascaris equorum and cyathostomes. Since foals do not show patent infections of 
these nematodes until two months of age, no foals younger than four months were 
utilized for this trial. Foals were allocated by age then randomly assigned into three 
treatment groups. Group I received ivermectin and praziquantel, trade name 
EQUIMAX™ (Pfizer Animal Health), at a dose of 0.2 mg/kg. Group II received 
ivermectin and praziquantel, (EQUIMAX™) at 0.2 mg/kg and a 13.2 mg/kg dose of 
pyrantel pamoate, trade name Strongid® Paste (Pfizer). Treatments were given 
simultaneously, instead of at two different times, so that the effects of one drug do not 
skew the results of the other drug. Group III was administered the Panacur® 
PowerPac™, (Intervet), which is a dose of fenbendazole at 20 mg/kg for five 
consecutive days. Every two months, the foals of similar age cohorts were regrouped by 
randomization as to give statistically stronger results.  At the end of six months, the most 
effective treatment regimen was applied to all foals. The ivermectin dose is the 
manufacturer’s recommended dose for cyathostomes and Parascaris while the pyrantel 
treatment is two times the labeled dose for Parascaris but is approved for use at this 
dose for Anoplocephala, the horse tapeworm. The fenbendazole Panacur® PowerPac™ 
treatment has been shown to not only kill adult cyathostomes, but also larvae that are 
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arrested in the intestinal wall (Steinbach et al., 2006) and is the approved dose for 
cyathostomes and Parascaris. 
 Fecal samples were taken at the time of treatment and at two week intervals post 
treatment.  In previous research, ivermectin was shown to produce false negatives in 
cyathostome numbers in early observations, thus samples taken one month after 
treatment may be more reliable than those taken two weeks post treatment (Lyons et al., 
2008b). The cause of the false negative is that some adult cyathostomes are not killed by 
the drug, but egg production is temporarily halted. Samples were obtained by putting 
each foal in a separate stall for approximately two hours to give ample time to defecate. 
The number of fecal eggs per gram (epg) was determined by the modified McMaster’s 
method; with a sensitivity of 25 eggs/gm. Twenty-eight milliliters of saturated NaCl 
solution (specific gravity of 1.20) were mixed with two grams of feces. The mixture was 
emulsified and then added to specifically designed counting slides with four grids being 
counted under 100 x magnification. Total number of eggs was multiplied by 25 to 
achieve eggs per gram (Herd, 1992). If either type of egg, Parascaris or cyathostomes, 
was not detected using the McMaster’s method, a five gram Wisconsin double 
centrifugation test was performed on the sample, with a sensitivity of 0.2 epg of feces. 
Five grams of feces was mixed with 35 ml of tap water, strained through a single layer 
of cheese cloth, then centrifuged for five minutes at 1300 rpm to sediment the eggs and 
other undigested material. The sediment was then mixed into a sucrose solution (specific 
gravity 1.26) in a 15 ml centrifuge tube filled to a positive meniscus; a cover slip was 
applied then was spun by centrifugation for 10 minutes at 1500 rpm (Todd et al., 1975). 
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A fecal egg count (FEC) reduction was then calculated using the mathematical average 
from each group sampled at the time of treatment compared to values obtained 14 and 28 
days later using the formula: 
 
 
FEC day of treatment – FEC 14 days post treatment  X100 
FEC day of treatment 
 
The average effects for each treatment group were analyzed, allowing for random effects 
for each individual (Littell et al., 1996). Resistant status was assigned to parasites that 
exhibited <90% reduction in accordance with the suggested recommendation (Kaplan et 
al., 2004). Fecal egg count reductions were calculated by mean epg counts per treatment 
group, and by egg count reductions per each individual foal in each treatment group. A 
repeated measures analysis of variance (ANOVA) model was performed on the FECR 
data from each individual foal per treatment group. Pair wise comparisons between 
groups were performed for variables which significantly affected the model using the 
Mann-Whitney rank sum test (STATA 10, College Station, TX).   
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3. RESULTS 
 
 
 
3.1 Cyathostomes 
 
 
 
After examining the data collected, we found that the 30 foals utilized for this 
study shed variable numbers of eggs, 1.6-6800 cyathostome eggs per gram of feces and 
0-8700 Parascaris epg of feces (complete results for all foals utilized can be found in the 
appendix). Based on the repeated measures ANOVA model, fecal egg counts were 
significantly (p<0.05) affected by treatment type, week, and treatment by week 
interaction. All three treatments reduced egg numbers at two weeks post treatment. The 
ivermectin and combination groups had a higher mean reduction rate for cyathostomes 
than did the fenbendazole treated group, 100% (99.9%) and 100% (100%) as compared 
to 94.1% (94.8%) respectively, the reduction percentages are individual reduction 
percentages, group percentages are in parentheses. Actual egg counts at two weeks post 
treatment varied in individual animals in each group with numbers ranging from 0-25 
epg in the Ivermectin group, 0-50 epg in the combination group, and 0-425 epg in the 
group treated with fenbendazole. Subsequent testing at four, six, and eight weeks post 
treatment showed increasing cyathostome egg counts in all treatment regimens.  
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The eight week post treatment egg counts ranged from 0-1175 epg for ivermectin 
with a mean of 270.9 epg, an 81.6% (89.1%) overall reduction in eggs per gram from the 
time of treatment. The combination treatment showed eggs per gram that ranged from 
5.6-6800 epg with a mean of 922.3 epg, a 66.1% (37.8%) reduction from the mean epg 
at time of treatment.  The fenbendazole treated group had epg’s ranging from 2.4-2325 
epg with a mean of 606.6, an overall reduction of 60.3% (67.2%) at eight weeks post 
treatment. The means, range, percent reductions, both by individual per group and per 
group epg reduction), is presented for cyathostome egg counts for each two week 
interval in Table 1. 
 The high effectiveness of both the combination treated group and the 
ivermectin treated group were found to be significantly different than the fenbendazole 
treated group, but not significantly different from each other at two weeks post 
treatment. This was also found to be the case at the four weeks post treatment as well. At 
six and eight weeks post treatment, no significant difference was found among the three 
treatment groups. 
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Table 1: Cyathostome Eggs per Gram (EPG) of Feces Results for Each Treatment 
over Time 
 Treatment 1 Treatment 2 Treatment 3 
 Ivermectin Combination Fenbendazole 
Mean EPG at Treatment                  
(50-6800 range)  
2493 
 (200-6800) 
1482 
 (350-4750) 
1848  
(50-5900) 
Mean EPG at 2 weeks  
(0-425 range) 
1.8  
(0-25) 
0  
(0-0.2) 
95.8  
(3.2-425) 
% Reduction at 2 weeks for 
Individuals  
100%a 100%a 94.1%b 
Group Mean % Reduction at 2 weeks  
Mean EPG at 4 weeks  
(0-1125 range) 
99.9%a 
11.3  
(0-100) 
100%a 
18.9 
(0-125) 
94.8%a 
329.2  
(10.6-925) 
% Reduction at 4 weeks for 
Individuals 
99.6%a 98.7%a 76.2%b 
Group Mean % Reduction at 4 weeks  
Mean EPG at 6 weeks  
(0-3450 range) 
99.6%a 
169.9  
(0-525) 
98.7%a 
399.1 
(0-3450) 
82.2%a 
480.6 
(8.4-1550) 
% Reduction at 6 weeks for 
Individuals 
87.4%a 80.%a 69%a 
Group Mean % Reduction at 6 weeks  
Mean EPG at 8 weeks  
(0-6800 range) 
93.2%a 
270.9 
(6-1175) 
73.1%a 
922.3 
(5.6-6800) 
74%a 
606.6 
(10-2325) 
% Reduction at 8 weeks for 
Individuals 
Group Mean % Reduction at 8 weeks  
81.6%a 
 
89.1a 
66.1%a 
 
37.8%b 
60.3%a 
 
67.2%ab 
             All means and standard deviations in epg 
           a,b means in the same row with unlike letters are significantly different (P<0.05) 
 
 
 
                                                         3.2 Parascaris 
 
 
 
Contrary to the cyathostome results, Parascaris egg counts were reduced the 
most   by fenbendazole at two weeks post treatment with a 100% (100%) reduction from 
mean egg counts with an average of 0.2 epg (0-2.6 epg). The combination group had a 
95.8% (93.1%) mean reduction with a mean of 42.7 epg (0-500 epg), followed by 
ivermectin with a 56.9% (60.3%) reduction from original mean egg counts with an 
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average of 776.8 epg (0-3325 epg) two weeks post treatment.  Unlike the cyathostomes, 
Parascaris egg counts fell in all subsequent testing to as low as zero eggs per gram in 
the fenbendazole treated group at eight weeks post treatment, in fact no Parascaris eggs 
were found in the fenbendazole group from four to eight weeks post treatment. Eight 
weeks post treatment, ivermectin treated foals had a mean of 46 epg (0-325 epg) and an 
overall reduction of 91.5% (97.6%)  Parascaris egg counts from the mean at time of 
treatment. The combination group had better effectiveness with egg counts averaging 10 
epg (0-75 epg), and a 99.3% (98.4%) overall reduction in treatment mean numbers. 
Table 2 indicates means, percent reductions, and standard deviations for Parascaris. 
Overall, there were more significant differences among each treatment for 
Parascaris than for the Cyathostomes. As seen on Table 2, the two and six weeks post 
treatment results showed a significance difference between the ivermectin treatment 
group and the other two groups, no significant difference was seen between the 
combination and fenbendazole groups at those times. At  four and eight weeks post 
treatment, Parascaris egg counts showed significant differences between the ivermectin 
and fenbendazole treatment groups, the combination group did not show significant 
differences between either of the other two groups. 
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Table 2: Parascaris Eggs per Gram (EPG) of Feces Results for Each Treatment 
over Time 
 Treatment 1 Treatment 2 Treatment 3 
 Ivermectin Combination Fenbendazole 
Mean EPG at Treatment  
(25-8700 range) 
1957.1 
(25-8700) 
621.7 
(50-2575) 
1480 
(25-8350) 
Mean EPG at 2 weeks  
(0-3325 range) 
776.8 
(0-3325) 
42.8 
(0-500) 
.2 
(0-2.6) 
% Reduction at 2 weeks for 
Individuals 
Group Mean % Reduction at 2 
weeks 
56.9%b 
 
60.3%b 
95.8%a 
 
93.1%ab 
100%a 
 
100%a 
Mean EPG at 4 weeks                      
(0-975 range) 
201.7 
(0-975) 
16.6 
(0-225) 
0 
(0) 
% Reduction at 4 weeks for 
Individuals 
Group Mean % Reduction at 4 
weeks 
83.7%a 
 
89.7%a 
99%ab 
 
97.3%a 
100%b 
 
100%a 
Mean EPG at 6 weeks  
(0-825 range) 
121  
(0-825) 
10.8 
(0-100) 
0 
(0) 
% Reduction at 6 weeks for 
Individuals 
Group Mean % Reduction at 6 
weeks 
74.9%b 
 
93.8%a 
99.4%a 
 
99.3%a 
100%a 
 
100%a 
Mean EPG at 8 weeks  
(0-325 range) 
46  
(0-325) 
10 
(0-75) 
0 
(0) 
% Reduction at 8 weeks for 
Individuals 
Group Mean% Reduction at 8 
weeks 
91.5%a 
 
97.6%a 
99.3%ab 
 
98.4%a 
100%b 
 
100%a 
              All means and standard deviations in epg  
            a,b means in the same row with unlike letters are significantly different (P<0.05) 
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4. DISCUSSION 
 
 
 
 The goal of this study was to determine the effect of specific 
anthelmintics, or a combination of anthelmintics on Parascaris and cyathostome egg 
counts in foals. The experiments used naturally infected foals ranging in age from four 
months at the beginning of the trial to 10 months at its conclusion, all of which were 
housed, fed, and treated at the Texas A&M University Horse Center. Since it is TAMU 
Horse Center practice to treat monthly with ivermectin, (Golden, 2011), the ivermectin 
treated group served as a quasi-control. None of the 30 animals showed clinical signs of 
disease and all 30 exhibited expected weight gain throughout the trial. 
Since only naturally infected foals were utilized, the risk of highly variable 
parasite burdens and egg counts was present. Consequently, a high degree of variation 
was observed among the animals used in this study. These variations may have also been 
affected by the fact that the horses used were born between late January and late May of 
2009, thus resulting in some animals having increased parasite burdens based on the 
availability of forage at the time of first grazing. In fact, foals born from the middle of 
February to the middle of March had the highest mean egg counts for cyathostomes and 
Parascaris at 4450 epg and 3245.8 epg respectively. Foals born after mid-March to early 
May had the lowest average egg counts at 1247.2 epg for cyathostomes and 904.17 epg 
for Parascaris. Because of such a massive difference in egg counts at the time of the 
initial treatment and the fact that drugs were randomly assigned to each animal every 
eight weeks, statistical comparison of treatment groups is difficult.  
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Significant differences among the three groups at each two week period post 
treatment were determined. These calculations were derived from the individual foal’s 
epg reduction percentages, not from group mean epg counts, to give a more accurate 
interpretation of the data by reducing the effect of zero egg counts at treatment. Group 
means do not take into account individual variation, and thus comparison of reduction 
percentages using this method would only yield a comparison of means, using the mean 
of each individual foal’s reduction percentages allows for variation and stronger 
statistical analysis. As seen in the tables, for the most part the individual foal’s egg 
reduction percentages and the group mean reduction percentages were similar for most 
collection times. However, differences can be seen, such as with cyathostomes  eight 
week post treatment were reduction percentages for the foals treated with the 
combination treatment was 66.1% reduction for individuals and 37.8% for group mean, 
and Parascaris  at six weeks post treatment for ivermectin was 74.9% for individuals 
and 93.8% for group mean reduction percentages.  
The differences outlined above can be explained by how each percentage was 
calculated. Individual FECR% utilizes each individual foal’s egg reduction percentage to 
find the reduction percentage for the group as a whole, while the group means reduction 
percentages are calculated by comparing the mean epgs of post treatment collections to 
the mean at treatment. Using individual FECR% allows the researcher to remove test 
subjects who had zero epg at all collection points from treatment to eight weeks post 
treatment because if no eggs were ever found, no FECR% can be calculated. It also 
dictates that if a zero epg is found at the time of treatment and any eggs are found any 
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subsequent collection time, the FECR% is zero. The group means epg reduction takes all 
epg data into account causing more outliers than the individual foal FECR% does, thus 
skewing the data more such as in the two examples stated above. This could was also 
seen when comparing the significance between individual percentage reductions and 
group mean reductions by the fact that only one significant difference was found for 
cyathostomes and one for Parascaris when group mean reductions were analyzed as 
opposed to multiple significant differences when comparing the individual percentage 
reductions.  
For cyathostomes, the ivermectin treatment and the combination treatment 
mirrored each other with no significant differences being detectable at all post treatment 
samplings. The fenbendazole group, however, was significantly different than the other 
groups at two and four weeks post treatment. At six and eight weeks post treatment, each 
group had no significant difference in FECR from each other. Reduction percentages for 
six and eight weeks post treatment were 87.4% and 81.6% for ivermectin, 80% and 
66.1% for the combination treatment, and 76.2% and 60.3% for the fenbendazole treated 
group. 
 The reason that the fenbendazole treatment group was significantly different that 
the other two groups was due to the fenbendazole treatment’s reduced effectiveness 
compared to the ivermectin and combination treated groups at those times. It is possible 
that larval cyathostomes arrested in the tissues could have emerged and matured in the 
time since treatment, but, according to the label, the fenbendazole treatment should have 
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killed the larval stages as well as the adults in the lumen of the intestine, thus preventing 
this from occurring.   
 Against Parascasris, the combination and fenbendazole treated groups showed 
no significant differences at two, four, six, or eight weeks post treatment. The ivermectin 
treated group continuously was significantly different that the fenbendazole treated 
group for all post treatment epg counts. The reasons for this mostly stem from 
ivermectin’s inability to effectively reduce Parascaris egg counts and fenbendazole’s 
almost total elimination of this parasite’s eggs in the feces. The ivermectin treated group 
was significantly different from the combination treated group at two and six weeks post 
treatment but no significant differences were found at four and eight weeks post 
treatment. While the combination treatment did reduce egg numbers by over 95%, it was 
still not quite as effective as fenbendazole, which had a 100% reduction rate at all post 
treatment egg counts. These finding indicates that even though ivermectin had over a 
90% reduction rate at six and eight weeks post treatment, the combination and 
fenbendazole treatment groups statistically were much more effective at reducing egg 
numbers initially at the time of treatment and over the eight week span between 
treatments. 
Each treatment was evaluated as to its effectiveness for both cyathostomes and 
Parascaris with theoretical reasons for each result. 
Ivermectin was effective for treating cyathostomes with a 99.9% reduction of 
mean egg counts at two weeks post treatment. This finding indicates that it still has 
greater than 95% fecal egg reduction effectiveness. This finding mirrors that of Craig et 
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al from 2004 and 2005 on the same farm. In that study, ivermectin’s percent reduction 
was also 99.9%. While this data does support ivermectin’s initial effectiveness at killing 
cyathostomes, there was a rise in egg numbers at four weeks post treatment, where the 
egg count reduction was 99.5%, less than the percent reduction at treatment, with some 
of the treated foals increasing from 0 epg to 100 epg between the two and four weeks 
post treatment evaluations. In subsequent collections, the effectiveness dropped even 
lower to 81.6% at eight weeks post treatment, with one foal having an egg count of 1175 
epg. It should also be noted that this particular foal had a count of only 200 cyathostome 
eggs per gram at the time of treatment supporting the observation that instead of 
reducing cyathostome egg counts, they increased substantially by eight weeks post 
treatment. The reasoning for this could be that a large influx of cyathostome larvae 
emerged from the mucosa after the initial population in the lumen had been removed, or 
the parasites in the lumen could have had their egg production halted without being 
killed. It is doubtful that egg production was halted for that long, but it could have 
contributed to the increase in egg numbers. The findings for the ivermectin treated group 
in general coincide with the studies of Lyons et al (2008b) and von-Samson-
Himmelstjerna et al (2006) in which they each state that egg counts for the ivermectin 
treated animals begin to return four weeks post treatment with more rapid increases at 
six and eight weeks post treatment. Previous research conducted in 1992 concluded that 
ivermectin controlled egg count numbers for eight weeks post treatment (Little et al., 
2003), studies performed by Lyons on the same farm as Little in 2007-2008 showed 
reduced numbers for only four weeks (Lyons et al, 2008a). A study performed by von-
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Samson-Himmelstjerna et al (2006) showed an increase in cyathostome egg numbers 
three weeks post treatment in 9 of 14 foals and yearlings from one farm; this increase 
was hypothesized to be caused by less efficient immune responses in those animals. 
However, after testing the body conditions of the 14 horses with similarly aged horses on 
other farms, no difference could be found to explain this occurrence. The evidence now 
points to the drug’s loss of effectiveness over time to control cyathostomes (von-
Samson-Himmelstjerna et al, 2006).  
 Ivermectin failed to provide control of Parascaris at two weeks post treatment. 
Not only did it not achieve the 95% egg reduction that is the standard for setting 
effectiveness measures, it only managed to reduce mean egg counts by 56.9%, based on 
individual foal FECR%, from the numbers present at the time of treatment. A more 
startling point is that Parascaris egg counts actually increased in one animal two weeks 
post treatment. This foal went from 925 epg to 975 epg. While this does not indicate that 
the parasite burden increased in this particular foal, it does lead to the conclusion that the 
Parascaris population was only minimally affected if affected at all. A 50 epg increase 
in two weeks can be attributed to regular fluctuations; however, being that the increase 
happened only two weeks post treatment is further evidence of Parascaris resistance to 
ivermectin. The two week mean percent reduction of 60.3% is even less that the 
reduction that Craig et al. (2007) found on this same farm in 2004-2005, which was 
84.8%. Although not the preferred choice for Parascaris treatment, ivermectin did show 
more effectiveness in the four, six, and eight week collections. The last collections had a 
total percent reduction of 91.5% with a range of 0-325 epg. Surprisingly, the reductions 
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were not linear; the foals with the highest initial counts had eight week egg counts near 
zero, while the foal with a starting level of less than 1000 epg had the highest eight week 
post treatment egg count. This observation could possibly be explained by the variation 
in number of migrating larvae and immature Parascaris in each individual foal as well 
as possibly the related to immunity that causes resistance to Parascaris after exposure 
and the loss of adult worms due to their sensitivity to the drug. The fact that ivermectin’s 
effectiveness increased over time can be explained by the drug’s mode of action on 
parasites.  
Macrocyclic lactones work by causing a flaccid paralysis, if this does not 
immediately kill the adults; it may have weakened them enough for the foal’s immune 
system to develop a response and may even assist in developing the natural immunity to 
Parascaris faster than the other drugs because of the parasite’s now inactive inhabitation 
in the small intestine. 
 The combination treatment showed 100% effectiveness at reducing cyathostome 
egg counts at two weeks post treatment with only one foal having any detectable epg 
levels, 0.2 epg; however, the subsequent collections showed a marked drop in 
effectiveness, with an overall reduction of only 66.1%, (37.8% based on group means), 
at the eight week collection. Two foals showed an increase in egg counts at the eight 
week post treatment collection, with one of them having a three-fold increase in egg 
numbers from those at the time of treatment, this is further evidence of ivermectin’s 
reduced longevity. At eight weeks post treatment, the egg counts ranged from 0-6800 
epg with eight animals being under 25 epg, six being over 700 epg, and four being 
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between 200-600 epg. This variation could have been due to the numbers of 
cyathostome larvae in the mucosa of the large intestine and the previous exposure of 
each individual animal. 
 As far as the Parascaris egg counts, the two week post treatment sampling 
revealed an overall mean percent reduction of 95.2% with a range of 0-500 epg. Just as 
had been observed with the group treated solely with ivermectin, the four, six, and eight 
week collections all had improved effectiveness over the two week post treatment 
counts, with a final reduction of 99.3% and a range of 0-75 epg. While the two week 
post treatment reductions failed to achieve the 95% egg reduction standard based on the 
group mean of 93.1%, the individual FECR% did meet the criteria for effectiveness both 
the group mean and individual foal FECR% were over 95% for the four, six, and eight 
week post treatment collections. Although the combination treatment was only 7.8% 
more effective at reducing egg counts than the ivermectin alone treatment, the initial 
reduction is worth the added drug administration because it lowers the number of   
Parascaris more quickly to begin with while still having the residual effect seen in the 
later samplings of the ivermectin treated group. Also, as had been reported in earlier 
research, ivermectin’s effect on Parascaris is less pronounced in older foals, this 
statement is supported by this study (Craig et al.,2007.). In the ivermectin treated group, 
four month old treated foals still had egg counts exceeding 2000 epg; some did not even 
achieve a 50% reduction at two weeks post treatment. By giving the combination of 
drugs to the foal, especially young ones, the initial Parascaris burdens can be drastically 
lowered quickly by pyrantel, while ivermectin’s residual effect can possibly supply some 
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sustained protection against Parascaris due to the observation that its effectiveness 
increased in the subsequent EPG tests after treatment. It should be noted that 
effectiveness may have been due more to acquired immunity than ivermectin’s 
effectiveness, but that can only be speculated.  
 The fenbendazole treated group had a 94.1% mean reduction in cyathostome egg 
counts two weeks post treatment with a range of 0-425 epg; however, subsequent 
collections found that effectiveness fell each two week interval to an eight weeks mean 
reduction of only 60.3% with a range of 2.4-2325 epg. This is a lower reduction than 
was seen at eight weeks in the ivermectin treated group. Though cyathostomes have 
been reported to have resistance to benzimidazoles, with one researcher stating that a 
single dose of fenbendazole is now ineffective at controlling cyathostomes on almost all 
farms in the southern US (Kaplan et al, 2004), this study utilized a double dose of the 
fenbendazole Powerpac® treatment, which is 20mg/kg for five consecutive days. 
Previous research done by Steinbach et al in 2006 showed that animals treated with this 
amount of fenbendazole shed no cyathostome eggs after treatment. Also, of the eight 
animals given the treatment in that study, only two of them had cyathostome adults 
present on the post mortem examination, and those two particular animals only harbored 
low numbers (under 50 adults) (Steinbach et al , 2006).  Comparing the findings of 
Steinbach to those seen in this study, resistance levels vary over geographic location and 
simply from farm to farm, making it necessary to test each individual farm to know 
which drugs are effective on parasite populations on those farms. 
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 The fenbendazole treatment group had one undeniable advantage over the other 
two treatment groups: the most effective reduction of Parascaris egg counts of all the 
treatment regimens. At two weeks post treatment, egg numbers where reduced by 99.9% 
from the time of treatment with only one foal having a detectable egg level, and that was 
only 2.4 epg. Following collections revealed no Parascaris eggs at all. This shows that 
the five day fenbendazole Powerpac at 20mg/kg treatment is effective against Parascaris 
on this particular farm.  
The data reveled in this study and the observations seen from previous work 
point to the conclusion that if we continue to try to treat all horses with a single 
anthelmintic, further resistances will occur. To add to this, with animals being routinely 
transported over long distances, the spread of resistant strains of worms is highly likely 
to occur. Since there is evidence that one common type of parasite is susceptible to one 
antihelmenthic and resistant to another, and the other most common is just the opposite, 
a dual dewormer approach seems reasonable.  
 
 
31 
 
5. CONCLUSION AND RECOMMENDATIONS 
 
 
 
 Although the fenbendazole did show the highest percent reduction rates for 
Parascaris, its inability to meet the 95% egg count reduction for cyathostomes at four 
weeks post treatment, as well as the necessity to be given for five consecutive days make 
it a less desirable treatment for this particular farm. Ivermectin’s ability to control 
cyathostomes was much greater four weeks post treatment with a percent reduction of 
99.5% compared to the fendendazole’s rate of 76.2% at four weeks. Though this does 
bode well for ivermectin, its effectiveness against Parascaris at four weeks was only a 
83.7% reduction from the numbers at the time of treatment. The combination treatment 
of ivermectin and pyrantel had the most effective results for both parasites with 
cyathostome egg counts falling by 98.7% four weeks post treatment and Paracaris egg 
count reductions of 99% from original numbers at four weeks post treatment. Therefore, 
it is believed that the combination treatment would provide the most protection to the 
foals at this particular farm for the time being.  
 The observation that the combination treatment offers the highest reductions in 
fecal egg counts of both parasites in this study strongly supports its use as a standard 
treatment for the facility. It is the recommendation of this researcher that the 
combination treatment should be administered to foals three months of age at the Texas 
A&M University Horse Center to cause not only a large reduction in adult worm 
populations, but more importantly, stop the large number of eggs these parasites would 
produce from contaminating the environment. This would diminish the exposure of 
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subsequent populations of foals in the following years, thus reducing the chance of 
disease over time. Since eggs of Parascaris equorum, can be viable for years after being 
passed in the environment, treatment at this point in the foals’ lives could provide a 
substantial exposure reduction to subsequent generations of foals born on this farm. 
From the data collected, foals who initially received the combination treatment showed 
no substantial Parascaris egg counts throughout the rest of the study, indicating that 
once the primary levels of this parasite have been treated, future numbers of reproducing 
adults are relatively controlled, even if subsequent treatments are not the combination 
treatment. Even though this study utilized foals as young as four months of age, this was 
only done to ensure substantial Parascaris egg numbers; three months is ample time to 
develop patent Parascaris infections since the parasite’s prepatent period is 75-80 days. 
 After the initial combination treatment, a monthly treatment of ivermectin is 
recommended to reduce the likelihood of cyathostome related disease, and provide some 
relief to Parascaris infections. This treatment regimen would continue to reduce 
cyathostome egg numbers in the environment, protecting not only the current population 
of foals, but future generations as well as adult horses on the farm since cyathostomes 
can infect equines of any age. The reason for using the ivermectin only treatment for 
Parascaris is that even though this study has proven that it does not reduce egg counts 
for this particular parasite to the standard 95% reduction rate at two weeks post 
treatment, it does show improved egg reduction numbers at four weeks through eight 
weeks post treatment. While no hard evidence has been uncovered by this study to 
suggest why this occurred, speculations can be made which include increased horse 
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immunity to Parascaris or if prolonged exposure to ivermectin is the cause of the 
decline in egg numbers.  
It should also be noted that the mares at the TAMU Horse Center share the same 
grazing areas as the foals. Because of this, the foals’ exposure to infective Parascaris is 
reduced. Parascaris should not mature in the mares because of acquired immunity, if 
they have had previous exposure to the parasite, thus contributing to a reduced amount 
of infective eggs ingested by the foals. Cyathostomes will mature in adult horses, but 
their numbers are usually lower than the numbers in foals, thus also reducing the foals’ 
exposure to cyathostomes as well. While egg per gram analysis was not conducted on 
mares at the TAMU Horse Center in this study, other research does support this 
hypothesis. It has been observed that, in general, egg counts are lower in mature horses 
than in foals. Research has also revealed that egg reappearance in feces is often longer 
and egg numbers lower in adult horses compared to foals (Klei, 1999). Though adult 
horses will not acquire complete immunity to cyathostomes with exposure and age the 
way they do to Parascaris, evidence shows that mature horses will develop age related 
resistance to large numbers of adult cyathostomes (Klei, 1999).  
Grazing both mares and foals together will not keep the foals from getting 
infected with intestinal parasites, but it can reduce the foal’s exposure to infective stages 
in the environment. If the mares undergo fecal egg count analysis, and treatment is 
administered only to mares with high egg counts as opposed to all mares each treatment 
cycle, pasture contamination by the mares would be reduced. This would also slow the 
development of anthelmintic resistance by letting the untreated mares serve as a 
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reservoir for cyathostomes that haven’t been exposed to anthelmintics on a regular 
basis. Reduction to infective parasites by combined mare and foal grazing was not 
purpose of the study, nor was it a parameter of it. It is only speculation as far as this 
particular horse farm goes, but it is a possibility for future research. 
The longevity of this treatment regimen cannot be extrapolated, thus future 
studies will need to be conducted to see if the combination treatment’s effectiveness has 
waned or continues to show the same level of effectiveness against cyathostomes and 
Parascaris, as well as that of ivermectin to those parasites. It should also be mentioned 
that this treatment is meant to control egg shedding levels, not eradicate parasite 
burdens. It is effectively treating one year’s foals to reduce the exposure of the next 
year’s animals. Also, the combination treatment is not meant to assist with the horse’s 
immunity development to Parascaris. The migrating Parascaris larvae are more 
responsible for acquired immunity than are the adults in the small intestine because 
when the larvae migrate through the liver, eosinophils, macrophages, neutrophils, and 
lymphocytes invade the tracts cut by the larvae in the liver and surround the parasite 
(Brown et al, 1979). As more larvae migrate through the liver, these cells and the 
cytokines produced by the host become more efficient at isolating the larvae and 
preventing migration and maturation. Also, pyrantel, unlike ivermectin, is not absorbed 
by the foal, thus the parasites do not have a prolonged exposure to pyrantel in this 
treatment regimen. The data from this study show that Parascaris egg counts fell over 
time in the ivermectin treated group from a mean of 776.8 epg at two weeks post 
treatment to one of 46 epg at eight weeks post treatment, a reduction of 91.5% at eight 
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weeks from counts at the time of treatment with most foals having no observable levels 
of eggs in the feces. This could be due ivermectin’s mode of action on the parasite 
causing the adults to be expelled from the body slower than with the pyrantel treatment, 
or at least reducing egg production for a time. It is not the purpose of this study to 
remark on this hypothesis; however, it is a possible basis for future research.  
This treatment regimen needs to be regularly evaluated for effectiveness. The 
monthly treatment of ivermectin is an ideal way to select for parasite resistance. The 
purpose of this study was to determine which of the three drugs were effective at the 
time of the study and for which parasites they were effective on, what will work in the 
future is unknown. It is the recommendation of this researcher that yearly evaluations of 
this treatment regimen be performed to test its continued effectiveness against 
cyathostomes and Parascaris. It is possible that after the initial treatment, monthly 
ivermectin treatments are not necessary, treatment may only be needed every two 
months. This would assist in prolonging the effectiveness of the anthelmintic by 
reducing the exposure of the parasites to it, as well as still providing sufficient protection 
to the foal. 
If future testing does indicate resistance to the treatment regimen by Parascaris 
on this farm, the effectiveness of both ivermectin and pyrantel will need to be 
reevaluated to determine which drug has failed. If ivermectin is found to have lost its 
effectiveness but pyrantel still works, a monthly dose of both drugs should be considered 
as a new treatment regimen. If pyrantel is found to failed, the fenbendazole Powerpac 
treatment should be considered as an option to control Parascaris. A single dose of 
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fenbendazole at 20 mg/kg (double the manufacturer’s recommended dose for Parascaris 
equorum) may be just as beneficial without the added need for the subsequent dosing 
that the Powerpac requires. The reason for suggesting a double dose at 20mg/kg instead 
of a single dose is because that was the amount of drug administered to the foals in the 
fenbendazole treatment group each day they received fenbendazole as part of the 
Powerpac regimen.  Recent research shows that it does have a high effectiveness against 
Parascaris; however, the effectiveness of a single fenbendazole dose was not evaluated 
as part of this study, and therefore its ability to control Parascaris on this farm is 
unknown at this time. 
 If the proposed treatment regimen loses its effectiveness at controlling 
cyathostomes, it is this researcher’s opinion that a new study be undertaken to determine 
an effective drug or combination of drugs that will control cyathostomes. Since 
ivermectin was the only drug tested in this study that showed an egg reduction of over 
90% one month after treatment, different anthelmintics than the ones used in this study 
should be evaluated for effectiveness. 
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APPENDIX 
 
 
 
STRONGYLE FECAL EGG COUNTS 
 
 
IVERMECTIN 
 
 
Animal ID # Weight DOB date Str EPG date Str EPG date Str EPG date Str EPG date Str EPG 
BJ 1 466 1/27/2009 18-Jun 2625 6-Jul 0 20-Jul 25 3-Aug 200 17-Aug 300 
Dixie 5 477 2/7/2009 18-Jun 3675 6-Jul 0 20-Jul 100 3-Aug 425 17-Aug  
Freddy 8 502 3/13/2009 20-Jul 5900 3-Aug 0 17-Aug 25 31-Aug 175 14-Sep 275 
Toad 10 405 3/23/2009 20-Jul 3000 3-Aug 0 17-Aug 0.8 31-Aug 675 14-Sep 250 
BJ 1 522 1/27/2009 17-Aug 300 31-Aug 0 14-Sep 0 28-Sep 0.4 12-Oct 0.2 
Willy 6 535 2/1/2009 17-Aug 450 31-Aug 0 14-Sep 0.2 28-Sep 0 12-Oct 0 
Mikey 14 490 3/28/2009 31-Aug 8.2 14-Sep 0 28-Sep 0 12-Oct 0 26-Oct 1.6 
Tito 16 446 4/8/2009 31-Aug 1975 14-Sep 0 28-Sep 0 12-Oct 0 26-Oct 50 
Maggie 23 416 5/9/2009 28-Sep 4375 12-Oct 25 26-Oct 0.8 9-Nov 75 23-Nov 475 
Luigi 24 438 5/10/2009 28-Sep 475 12-Oct 0 26-Oct 0 9-Nov 100 23-Nov 350 
 25 389 5/27/2009 12-Oct 200 26-Oct 0 9-Nov 2.4 23-Nov 525 7-Dec 1175 
 28 472 5/18/2009 12-Oct 2175 26-Oct 0 9-Nov 0 23-Nov 150 7-Dec 250 
Streak 15 580 4/19/2009 26-Oct 200 9-Nov 0 23-Nov 0 7-Dec 0 21-Dec 12.4 
George 17 541 3/17/2009 26-Oct 10 9-Nov 0 23-Nov 0 7-Dec 0.2 21-Dec 1 
Mario 19 450 5/10/2009 23-Nov 2250 7-Dec 0 21-Dec 1.4 4-Jan 17.6 18-Jan 28.6 
Homer 22 388 5/7/2009 23-Nov 225 7-Dec 0 21-Dec 0 4-Jan 3 18-Jan 50 
 27  5/27/2009 7-Dec 6800 21-Dec 0 4-Jan 2.6 18-Jan 31.4 1-Feb 300 
 29  5/15/2009 7-Dec 1025 21-Dec 0 4-Jan 0 18-Jan 1 1-Feb 6 
mean     1982 2 weeks 1.4 4 weeks 8.8 6 weeks 132.1 8 weeks 207.4 
% red     100  99.9    93.8  89.5 
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COMBINATION 
 
 
Animal ID # Weight DOB date Str EPG date Str EPG date Str EPG date Str EPG date Str EPG 
Charlie 2 391 2/7/2009 18-Jun 2225 6-Jul 0 20-Jul 25 3-Aug 575 17-Aug 1750 
Willy 6 456 2/1/2009 18-Jun 550 6-Jul 0 20-Jul 50 3-Aug 525 17-Aug 450 
Toots 7 481 2/26/2009 20-Jul 4525 3-Aug 50 17-Aug 25 31-Aug 375 14-Sep 750 
Catfish 12 493 2/25/2009 20-Jul 4750 3-Aug 0 17-Aug 50 31-Aug 350 14-Sep 700 
Charlie 3 513 2/2/2009 17-Aug 400 31-Aug 0 14-Sep 0.2 28-Sep 0 12-Oct 0.4 
Dixie 5 516 2/4/2009 17-Aug  31-Aug 0 14-Sep 0 28-Sep 0.4 12-Oct 0 
Streak 15 534 4/19/2009 31-Aug 2025 14-Sep 0 28-Sep 0 12-Oct 75 26-Oct 200 
George 18 476 5/6/2009 31-Aug 1425 14-Sep 0 28-Sep 3 12-Oct 375 26-Oct 575 
Mario 19 450 5/10/2009 28-Sep 1725 12-Oct 0 26-Oct 3.6 9-Nov 325 23-Nov 2250 
Homer 22 388 5/7/2009 28-Sep 2250 12-Oct 0 26-Oct 25 9-Nov 50 23-Nov 225 
 27 492 5/27/2009 12-Oct 2025 26-Oct 0 9-Nov 125 23-Nov 3450 7-Dec 6800 
 30 381 5/30/2009 12-Oct 1375 26-Oct 0 9-Nov 0 23-Nov 250 7-Dec 825 
Mudpie 13 544 3/28/2009 26-Oct 350 9-Nov 0 23-Nov 0 7-Dec 0 21-Dec 23 
Bozo 18 502 5/6/2009 26-Oct 525 9-Nov 0 23-Nov 0 7-Dec 0.8 21-Dec 7.8 
Marge 20 471 5/12/2009 23-Nov 375 7-Dec 0 21-Dec 0 4-Jan 5.2 18-Jan 6 
Luigi 24 438 5/10/2009 23-Nov 350 7-Dec 0.2 21-Dec 2.2 4-Jan 2 18-Jan 9.4 
 26  6/4/2009 7-Dec 1450 21-Dec 0 4-Jan 0 18-Jan 2 1-Feb 8.4 
 30  5/30/2009 7-Dec 825 21-Dec 0 4-Jan 0 18-Jan 2.2 1-Feb 5.6 
mean     1508 2 week 2.8 4 weeks 15.8 6-week 353.5 8-week 810.3 
% red       99.8  99  76.6  46.3 
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FENBENDAZOLE 
 
 
Animal ID # Weight DOB date Str EPG date Str EPG date Str EPG date Str EPG date Str EPG 
Oscar 3 434 2/2/2009 18-Jun 875 6-Jul 150 20-Jul 450 3-Aug 350 17-Aug 400 
Big John 4 486 2/4/2009 18-Jun 3050 6-Jul 125 20-Jul 225 3-Aug 350 17-Aug 525 
Turtle 9 470 3/5/2009 20-Jul 2625 3-Aug 125 17-Aug 350 31-Aug 500 14-Sep 450 
Russel 11 488 2/14/2009 20-Jul 5900 3-Aug 250 17-Aug 925 31-Aug 450 14-Sep 250 
Charlie 2 473 2/7/2009 17-Aug 1750 31-Aug 0 14-Sep 175 28-Sep 1.4 12-Oct 20 
Big John 4 579 2/4/2009 17-Aug 525 31-Aug 0 14-Sep 250 28-Sep 400 12-Oct 9.8 
Mudpie 13 515 3/28/2009 31-Aug 675 14-Sep 3.2 28-Sep 125 12-Oct 175 26-Oct 350 
George 17 483 3/17/2009 31-Aug 1375 14-Sep 25 28-Sep 75 12-Oct 25 26-Oct 10 
Marge 20 471 5/12/2009 28-Sep 2150 12-Oct 19.8 26-Oct 200 9-Nov 450 23-Nov 375 
Taco 21 495 5/1/2009 28-Sep 3325 12-Oct 175 26-Oct 1125 9-Nov 1475 23-Nov 2325 
 26 416 6/4/2009 12-Oct 1025 26-Oct 25 9-Nov 375 23-Nov 1550 7-Dec 1450 
 29 462 5/15/2009 12-Oct 2450 26-Oct 10.2 9-Nov 200 23-Nov 250 7-Dec 1025 
Mikey 14 504 3/28/2009 26-Oct 1.6 9-Nov 0.6 23-Nov 2 7-Dec 3.8 21-Dec 2.4 
Tito 16 493 4/8/2009 26-Oct 50 9-Nov 4.2 23-Nov 10.6 7-Dec 8.4 21-Dec 21.6 
Taco 21 495 5/1/2009 23-Nov 2325 7-Dec 425 21-Dec 375 4-Jan 825 18-Jan 1375 
Maggie 23 416 5/9/2009 23-Nov 475 7-Dec 25 21-Dec 27.4 4-Jan 100 18-Jan 17.4 
 25  5/27/2009 7-Dec 1175 21-Dec 50 4-Jan 175 18-Jan 125 1-Feb 275 
 28  5/18/2009 7-Dec 250 21-Dec 25 4-Jan 300 18-Jan 575 1-Feb 250 
mean     1667 2 week 79.9 4 weeks 298.1 6 weeks 423 8-week 507.3 
% red       95.2  82.1  74.6  69.6 
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PARACARIS FECAL EGG COUNTS 
 
 
IVERMECTIN 
 
 
Animal ID # Weight DOB date ParEPG date ParEPG date ParEPG date ParEPG date ParEPG 
BJ 1 466 1/27/2009 18-Jun 4350 6-Jul 175 20-Jul 0 3-Aug 1.8 17-Aug 1.2 
Dixie 5 477 2/7/2009 18-Jun 1175 6-Jul 2100 20-Jul 325 3-Aug 700 17-Aug  
Freddy 8 502 3/13/2009 20-Jul 6125 3-Aug 3325 17-Aug 725 31-Aug 0 14-Sep 0 
Toad 10 405 3/23/2009 20-Jul 2900 3-Aug 575 17-Aug 5.2 31-Aug 0 14-Sep 0 
BJ 1 522 1/27/2009 17-Aug 1.2 31-Aug 0 14-Sep 0 28-Sep 0 12-Oct 0 
Willy 6 535 2/1/2009 17-Aug 0 31-Aug 0 14-Sep 0 28-Sep 0 12-Oct 0 
Mikey 14 490 3/28/2009 31-Aug 0 14-Sep 0 28-Sep 0 12-Oct 0 26-Oct 0.6 
Tito 16 446 4/8/2009 31-Aug 925 14-Sep 700 28-Sep 975 12-Oct 825 26-Oct 325 
Maggie 23 416 5/9/2009 28-Sep 925 12-Oct 100 26-Oct 11.4 9-Nov 5.8 23-Nov 75 
Luigi 24 438 5/10/2009 28-Sep 8700 12-Oct 2650 26-Oct 700 9-Nov 1.4 23-Nov 0 
 25 389 5/27/2009 12-Oct 350 26-Oct 275 9-Nov 75 23-Nov 100 7-Dec 175 
 28 472 5/18/2009 12-Oct 1875 26-Oct 950 9-Nov 8 23-Nov 0 7-Dec 0 
Streak 15 580 4/19/2009 26-Oct 0 9-Nov 0 23-Nov 0 7-Dec 20.6 21-Dec 20.4 
George 17 541 3/17/2009 26-Oct 0 9-Nov 0 23-Nov 0 7-Dec 0 21-Dec 0 
Mario 19 450 5/10/2009 23-Nov 25 7-Dec 0 21-Dec 0 4-Jan 11.6 18-Jan 0 
Homer 22 388 5/7/2009 23-Nov 50 7-Dec 25 21-Dec 4.6 4-Jan 25.8 18-Jan 0 
 27  5/27/2009 7-Dec 0 21-Dec 0 4-Jan 2 18-Jan 2.4 1-Feb 0.6 
 29  5/15/2009 7-Dec 0 21-Dec 0 4-Jan 0 18-Jan 0 1-Feb 1.2 
mean     1481 2 weeks 604 4 weeks 157.3 6 weeks 94.1 8 weeks 35.2 
% red     100  59.2  92.1  93.6  97.6 
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COMBINATION 
 
 
Animal ID # Weight DOB date ParEPG date ParEPG date ParEPG date ParEPG date ParEPG 
Charlie 2 391 2/7/2009 18-Jun 1000 6-Jul 0 20-Jul 0 3-Aug 0 17-Aug 0 
Willy 6 456 2/1/2009 18-Jun 1300 6-Jul 0 20-Jul 0 3-Aug 0 17-Aug 0 
Toots 7 481 2/26/2009 20-Jul 1325 3-Aug 775 17-Aug 150 31-Aug 0 14-Sep 0 
Catfish 12 493 2/25/2009 20-Jul 750 3-Aug 75 17-Aug 0 31-Aug 0 14-Sep 0 
Charlie 3 513 2/2/2009 17-Aug 0 31-Aug 0 14-Sep 0 28-Sep 0 12-Oct 0 
Dixie 5 516 2/4/2009 17-Aug  31-Aug 25 14-Sep 0 28-Sep 0.2 12-Oct 0.2 
Streak 15 534 4/19/2009 31-Aug 1750 14-Sep 1 28-Sep 0 12-Oct 0 26-Oct 0 
George 18 476 5/6/2009 31-Aug 50 14-Sep 0 28-Sep 0 12-Oct 0 26-Oct 0 
Mario 19 450 5/10/2009 28-Sep 2575 12-Oct 500 26-Oct 225 9-Nov 100 23-Nov 25 
Homer 22 388 5/7/2009 28-Sep 975 12-Oct 50 26-Oct 0 9-Nov 12.6 23-Nov 50 
 27 492 5/27/2009 12-Oct 325 26-Oct 3.2 9-Nov 0 23-Nov 0 7-Dec 0 
 30 381 5/30/2009 12-Oct 600 26-Oct 12.2 9-Nov 0.2 23-Nov 0 7-Dec 0 
Mudpie 13 544 3/28/2009 26-Oct 0 9-Nov 0 23-Nov 0 7-Dec 0 21-Dec 0 
Bozo 18 502 5/6/2009 26-Oct 0 9-Nov 0 23-Nov 23.6 7-Dec 50 21-Dec 75 
Marge 20 471 5/12/2009 23-Nov 0 7-Dec 0 21-Dec 0 4-Jan 0 18-Jan 0 
Luigi 24 438 5/10/2009 23-Nov 0 7-Dec 0 21-Dec 0 4-Jan 0 18-Jan 0 
 26  6/4/2009 7-Dec 0 21-Dec 0 4-Jan 0 18-Jan 0 1-Feb 0 
 30  5/30/2009 7-Dec 0 21-Dec 0 4-Jan 0 18-Jan 0 1-Feb 0.2 
mean     589 2 week 80.1 4 weeks 22.6 6-week 9 8-week 8.4 
% red       86.4  96.2  98.5  98.6 
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FENBENDAZOLE 
 
 
Animal ID # Weight DOB date Par EPG date Par EPG date Par EPG date Par EPG date Par EPG 
Oscar 3 434 2/2/2009 18-Jun 6575 6-Jul 0 20-Jul 0 3-Aug 0 17-Aug 0 
Big John 4 486 2/4/2009 18-Jun 875 6-Jul 0 20-Jul 0 3-Aug 0 17-Aug 0 
Turtle 9 470 3/5/2009 20-Jul 8350 3-Aug 0 17-Aug 0 31-Aug 0 14-Sep 0 
Russel 11 488 2/14/2009 20-Jul 25 3-Aug 0 17-Aug 0 31-Aug 0 14-Sep 0 
Charlie 2 473 2/7/2009 17-Aug 0 31-Aug 0 14-Sep 0 28-Sep 0 12-Oct 0 
Big John 4 579 2/4/2009 17-Aug 0 31-Aug 0 14-Sep 0 28-Sep 0 12-Oct 0 
Mudpie 13 515 3/28/2009 31-Aug 600 14-Sep 0 28-Sep 0 12-Oct 0 26-Oct 0 
George 17 483 3/17/2009 31-Aug 2100 14-Sep 0 28-Sep 0 12-Oct 0 26-Oct 0 
Marge 20 471 5/12/2009 28-Sep 425 12-Oct 0 26-Oct 0 9-Nov 0 23-Nov 0 
Taco 21 495 5/1/2009 28-Sep 275 12-Oct 0 26-Oct 0 9-Nov 0 23-Nov 0 
 26 416 6/4/2009 12-Oct 200 26-Oct 0 9-Nov 0 23-Nov 0 7-Dec 0 
 29 462 5/15/2009 12-Oct 2200 26-Oct 0 9-Nov 0 23-Nov 0 7-Dec 0 
Mikey 14 504 3/28/2009 26-Oct 0.6 9-Nov 0 23-Nov 0 7-Dec 0 21-Dec 0 
Tito 16 493 4/8/2009 26-Oct 325 9-Nov 0 23-Nov 0 7-Dec 0 21-Dec 0 
Taco 21 495 5/1/2009 23-Nov 0 7-Dec 2.6 21-Dec 0 4-Jan 0 18-Jan 0 
Maggie 23 416 5/9/2009 23-Nov 75 7-Dec 0 21-Dec 0 4-Jan 0 18-Jan 0 
 25  5/27/2009 7-Dec 175 21-Dec 0 4-Jan 0 18-Jan 0 1-Feb 0 
 28  5/18/2009 7-Dec 0 21-Dec 0 4-Jan 0 18-Jan 0 1-Feb 0 
mean     1233 2 week 0.1 4 weeks 0 6 weeks 0 8-week 0 
% red       99.9  100  100  100 
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